Does arousal frequency predict daytime function?
R N Kingshott, H M Engleman, I J Deary, N J Douglas, R N Kingshott, H M Engleman, I J Deary, N J Douglas
Abstract
Patients with the sleep apnoea/hypopnoea syndrome (SAHS) have impaired daytime function with demonstrable sleepiness and impaired cognition. The hypothesis that brief arousals from sleep cause these daytime impairments was tested. One hundred and fifty patients with sleep disordered breathing were studied prospectively, comparing overnight polysomnography with daytime measures of objective sleepiness, psychological well-being and cognitive performance. Significant, but weak (r2<0.1), relationships were seen between several nocturnal measures (apnoea/hypopnoea index, arousals and desaturation variables) and daytime measures of quality of life, well-being, subjective sleepiness, symptoms and cognitive performance. The only significant relationship between nocturnal variables and objective sleepiness was a very weak correlation (r2<0.05) between the lowest oxygen saturation and mean maintenance of wakefulness test (MWT) result. The MWT was better correlated with daytime function than the multiple sleep latency test. This study shows a lack of strong relationships between conventional nocturnal measures and daytime function in patients with sleep disordered breathing.
Source: PubMed
Prossimi studi clinici
-
NCT07826949Non ancora reclutamentoGlioma | Neoplasia cerebrale | Gliomi ricorrenti di alto grado
-
NCT07826962Non ancora reclutamentoCoinvolgimento del paziente
-
NCT07826975Non ancora reclutamento
-
NCT07826988Non ancora reclutamentoAnemia falciforme | Crisi vaso-occlusiva
-
NCT07827001ReclutamentoCancro al cervello | Cancro al SNC | Cancro del sistema nervoso | Metastasi del Cancro al Cervello
-
NCT07827027Non ancora reclutamento
-
NCT07827040ReclutamentoAdulti | Assistenza digitale per ipovedenti | Deficit Visivi
-
NCT07827053Non ancora reclutamentoAdenocarcinoma duttale pancreatico (PDAC)
-
NCT07827066Non ancora reclutamentoSmettere di fumare | Agente AI | Early-Stage Cancer
-
NCT07827131Non ancora reclutamento